Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

NCT07410390
completednot_applicable

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

NCT04935151
completednot_applicable

HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial

NCT04143399

Clinical Trials (3)

Showing 3 of 3 trials
NCT07410390Not Applicable

Short Term Outcomes Of Bipolar Prostate Resection (BPR) Versus Diode Laser Ablation Versus Holmium Laser Enucleation Of Prostate Above 80 Grams With Minimum One Year Follow Up Duration.

Not Yet Recruiting
NCT04935151Not Applicable

HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH

Completed
NCT04143399Not Applicable

HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3